Clinical evaluation of the role of the autonomic nervous system in ventricular arrhythmias

  • Philippe Coumel
  • Jean-François Leclercq
  • Jean-Sylvain Hermida
  • Marc Zimmerman
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 71)


The role of the autonomic nervous system (ANS) in ventricular arrhythmias is a very wide topic which may be evaluated clinically from many different aspects. The present chapter does not pretend to cover in depth all of them, but simply to remind the clinician what evidences he has of the importance of this role, what tools he has at his disposal to explore it, and what difficulties he will meet when using them.


Ventricular Tachycardia Ventricular Arrhythmia Autonomic Nervous System Sinus Rate Right Bundle Branch Block 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Randall WC, Euler DE, Jacobs HK, Wehrmacher W, Kaye MP, Hageman GR. 1976. Autonomic neural control of cardiac rhythm: the role of autonomic imbalance in the genesis of cardiac dysrhythmias. Cardiology 61: 20.PubMedCrossRefGoogle Scholar
  2. 2.
    Verrier RL. 1980. Neural factors in ventricular electrical instability. In ‘Sudden Death’, HE Kulbertus & HJJ Wellens edit, Martinus Nijhoff Publ, The Hague/Boston/London, p. 137–155.Google Scholar
  3. 3.
    Schwartz PJ, Periti M, Malliani A. 1975. The long Q-T syndrome. Am Heart J 89: 378.PubMedCrossRefGoogle Scholar
  4. 4.
    Coumel Ph, Leclercq JF, Lucet V. 1985. Possible mechanisms of the arrhythmias in the long QT syndrome. In ‘Prolonged ventricular repolarization. Benefits and drawbacks’, P Amlie Ed. Eur Heart J 6D: 115–29.Google Scholar
  5. 5.
    Coumel Ph. 1987. The management of clinical arrhythmias. An overview on invasive versus noninvasive electrophysiology. Eur Heart J 8: 92.PubMedGoogle Scholar
  6. 6.
    Brugada P, Wellens HJJ. 1984. Standard diagnostic programmed electrical stimulation protocols in patients with paroxysmal recurrent tachycardias. Pace 7: 1121–8.PubMedGoogle Scholar
  7. 7.
    Campbell RWF, Gardiner P, Amos PA, Chadwick D, Jordan RS. 1985. Measurement of the QT interval. Eur Heart J 6D: 81–4.Google Scholar
  8. 8.
    Romano M, Di Maro T, Garella G, Cotecchia MR, Ferro G, Chiariello M. 1985. Relation between heart rate and QT interval in exercise-induced myocardial ischemia. Am J Cardiol 56: 861–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Zimmerman M, Maisonblanche P, Cauchemez B, Leclercq JF, Coumel Ph. 1986. Déterminants de l’activité répétitive dans les tachy car dies ventriculaires en salves. Arch mal Coeur 79:1420.Google Scholar
  10. 10.
    Zimmermann M, Maisonblanche P, Cauchemez B, Leclercq JR, Coumel Ph. 1986. Déterminants of the repetitive activity in benign incessant monomorphic ventricular tachycardia. JACC 7:1219.PubMedGoogle Scholar
  11. 11.
    Coumel Ph, Leclercq JF, Maisonblanche P, Attuel P, Cauchemez B. 1985. Computerized analysis of dynamic electrocardiograms: a tool for comprehensive electrophysiology. A description of the ATREC II system. Clin Progress 3:181–201.Google Scholar
  12. 12.
    Platia EV, Reid PR. 1985. Nonsustained ventricular tachycardia during programmed ventricular stimulation: criteria for a positive test. Am J Cardiol 56: 79–83.PubMedCrossRefGoogle Scholar
  13. 13.
    Coumel Ph, Rosengarten MD, Leclercq JF, Attuel P. 1982. Role of sympathetic nervous system in non-ischaemic ventricular arrhythmias. Br Heart J 47: 137–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Escoubet B, Leclercq JF, Maisonblanche P, Poirier JM, Gourmel B, Delhotal-Landes B, Coumel Ph. 1986. Dose-related effect of four beta-blockers on heart rate assessed by 24-hour recordings. Clin Pharmacol Ther 39: 361.PubMedCrossRefGoogle Scholar
  15. 15.
    Leclercq JF, Rosengarten MD, Kural S, Attuel P, Coumel Ph. 1981. Effects of betablocker’s intrinsic sympathetic activity on SA and AV nodes in man. Europ J Cardiol 12: 367–75.Google Scholar
  16. 16.
    Bristow MR, Laser JA, Minöbe W, Ginsburg R, Fowler MB, Rassmussen R. 1984. Selective down regulation of beta 1 adrenergic receptors in failing human heart. Circulation 70: suppl. II, 117.Google Scholar
  17. 17.
    Hermida JJ, Coumel Ph, Leclercq JF, Cauchemez B, Maison Blanche P, Leenhardt A, Slama R. 1987. Apport des bêta-bloquants dans le traitement des tachycardies ventriculaires résistantes chez l’insuffisant cardiaque. Arch Mal Coeur 80: 290.PubMedGoogle Scholar
  18. 18.
    Yussuf S, Peto R, Lewis J, Collins R, Sleight P. 1985. Beta-blockade during and after myocardial infarction. An overview of the randomized trials. Prog Cardiovasc Dis 77: 335.CrossRefGoogle Scholar
  19. 19.
    Kjekshus J. 1985. Beta-blockers: heart rate reduction, a mechanism of benefit. Eur Heart J 6 (suppl. A): 29–30.Google Scholar
  20. 20.
    IMPACT RESEARCH GROUP. 1984. International Mexiletine and Placebo Antiarrhythmic Coronary Trial: I. Report on arrhythmia and other findings. JACC 4: 1148–63.Google Scholar
  21. 21.
    Vaugham-Williams EM. 1982. Beta-blockers in the control of arrhythmias. In ‘Advances in beta-blocker therapy II’, A Zanchetti ed, Excepta Medica, Amsterdam-Oxford-Princeton publ. p. 110–6.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht 1987

Authors and Affiliations

  • Philippe Coumel
    • 1
  • Jean-François Leclercq
    • 1
  • Jean-Sylvain Hermida
    • 1
  • Marc Zimmerman
    • 1
  1. 1.Hôpital LariboisièreParisFrance

Personalised recommendations